Forward Pharma Operations ApS: Financial statements 2022
CVR: 38757504
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Forward Pharma Operations ApS (CVR 38757504) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 724,020 and a net result of DKK -27,022,415 compared with DKK -9,486,972 the year before. That is an increase of 16.5% compared with the year before. The profit margin was -3,732.3%. Equity in the 2022 report amounted to DKK 278,082,931. The solvency ratio was 91.1%.
- Revenue
- DKK 724,020
- Gross Profit
- DKK -7,895,217
- Profit/Loss
- DKK -27,022,415
- Equity
- DKK 278,082,931
- Total Assets
- DKK 305,108,786
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 724 t. | -7.9 mio. | -27 mio. | 278.1 mio. | - |
| 2021 | 622 t. | -9 mio. | -9.5 mio. | 305.1 mio. | - |
| 2020 | 351 t. | -8.2 mio. | -10.1 mio. | 314.6 mio. | - |
| 2019 | 327 t. | -11.3 mio. | -7.5 mio. | 324.7 mio. | - |
| 2018 | 105 t. | -27.1 mio. | -15.8 mio. | 332.2 mio. | - |
Official annual report
Keep an eye on Forward Pharma Operations ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Forward Pharma Operations ApS has published its annual report for 2021. Revenue came to DKK 621,559, and the net result was DKK -9,486,972.
About Forward Pharma Operations ApS
Forward Pharma Operations ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 30 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2024, the company reported revenue of DKK 99,127 and a net result of DKK -68,343,758 compared with DKK 1,043,207 the year before. Equity in the 2024 report amounted to DKK 280,041,147.